CANGEMI, Luigi
CANGEMI, Luigi
SCIENZA E TECNOLOGIA DEL FARMACO
Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
2021-01-01 Federica Bessone, Chiara Dianzani, Monica Argenziano, Luigi Cangemi, Rita Spagnolo, Federica Maione, Enrico Giraudo, Roberta Cavalli
Analyzing Cysteine Site Neighbors in Proteins to Reveal Dimethyl Fumarate Targets
2019-01-01 Rosa A.C.; Benetti E.; Gallicchio M.; Boscaro V.; Cangemi L.; Dianzani C.; Miglio G.
Beyond oncological hyperthermia: Physically drivable magnetic nanobubbles as novel multipurpose theranostic carriers in the central nervous system
2020-01-01 Ficiara E.; Ansari S.A.; Argenziano M.; Cangemi L.; Monge C.; Cavalli R.; D'Agata F.
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer
2018-01-01 Ciamporcero, Eric; Daga, Martina; Pizzimenti, Stefania; Roetto, Antonella; Dianzani, Chiara; Compagnone, Alessandra; Palmieri, Antonietta; Ullio, Chiara; Cangemi, Luigi; Pili, Roberto; Barrera, Giuseppina
Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats.
2012-01-01 Racca S; Piccione F; Spaccamiglio A; Carriero VM; De Francia S; Cangemi L; Esculapio P; Papotti M; Migliaretti G; Portaleone P; Di Carlo F; Abbadessa G.
Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment
2020-01-01 Dianzani C.; Monge C.; Miglio G.; Serpe L.; Martina K.; Cangemi L.; Ferraris C.; Mioletti S.; Osella S.; Gigliotti C.L.; Boggio E.; Clemente N.; Dianzani U.; Battaglia L.
Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment
2005-01-01 Rota E; Broda R; Cangemi L; Migliaretti G; Paccotti P; Rosso C; Torre E; Zeppegno P; Portaleone P
Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment
2022-01-01 Monge, Chiara; Stoppa, Ian; Ferraris, Chiara; Bozza, Annalisa; Battaglia, Luigi; Cangemi, Luigi; Miglio, Gianluca; Pizzimenti, Stefania; Clemente, Nausicaa; Gigliotti, Casimiro Luca; Boggio, Elena; Dianzani, Umberto; Dianzani, Chiara
Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro and in vivo studies
2018-01-01 Clemente, Nausicaa; Ferrara, Benedetta; Gigliotti, Casimiro Luca; Boggio, Elena; Capucchio, Maria Teresa; Biasibetti, Elena; Schiffer, Davide; Mellai, Marta; Annovazzi, Laura; Cangemi, Luigi; Muntoni, Elisabetta; Miglio, Gianluca; Dianzani, Umberto; Battaglia, Luigi*; Dianzani, Chiara
The activation of glucocorticoid system that follows acute stressor exposure is blocked by alpha-MSH.
2003-01-01 Spaccamiglio A.; Abbadessa G; Cangemi L; Esculapio P; Portaleone P; Racca S; Di Carlo F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance | 2021 | Federica Bessone, Chiara Dianzani, Monica Argenziano, Luigi Cangemi, Rita Spagnolo, Federica Maione, Enrico Giraudo, Roberta Cavalli | |
| Analyzing Cysteine Site Neighbors in Proteins to Reveal Dimethyl Fumarate Targets | 2019 | Rosa A.C.; Benetti E.; Gallicchio M.; Boscaro V.; Cangemi L.; Dianzani C.; Miglio G. | |
| Beyond oncological hyperthermia: Physically drivable magnetic nanobubbles as novel multipurpose theranostic carriers in the central nervous system | 2020 | Ficiara E.; Ansari S.A.; Argenziano M.; Cangemi L.; Monge C.; Cavalli R.; D'Agata F. | |
| Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer | 2018 | Ciamporcero, Eric; Daga, Martina; Pizzimenti, Stefania; Roetto, Antonella; Dianzani, Chiara; Compagnone, Alessandra; Palmieri, Antonietta; Ullio, Chiara; Cangemi, Luigi; Pili, Roberto; Barrera, Giuseppina | |
| Effects of sub-chronic nandrolone administration on hormonal adaptive response to acute stress in rats. | 2012 | Racca S; Piccione F; Spaccamiglio A; Carriero VM; De Francia S; Cangemi L; Esculapio P; Papotti M; Migliaretti G; Portaleone P; Di Carlo F; Abbadessa G. | |
| Nanoemulsions as delivery systems for poly-chemotherapy aiming at melanoma treatment | 2020 | Dianzani C.; Monge C.; Miglio G.; Serpe L.; Martina K.; Cangemi L.; Ferraris C.; Mioletti S.; Osella S.; Gigliotti C.L.; Boggio E.; Clemente N.; Dianzani U.; Battaglia L. | |
| Neuroendocrine (HPA axis) and clinical correlates during fluvoxamine and amitriptyline treatment | 2005 | Rota E; Broda R; Cangemi L; Migliaretti G; Paccotti P; Rosso C; Torre E; Zeppegno P; Portaleone P | |
| Parenteral Nanoemulsions Loaded with Combined Immuno- and Chemo-Therapy for Melanoma Treatment | 2022 | Monge, Chiara; Stoppa, Ian; Ferraris, Chiara; Bozza, Annalisa; Battaglia, Luigi; Cangemi, Luigi; Miglio, Gianluca; Pizzimenti, Stefania; Clemente, Nausicaa; Gigliotti, Casimiro Luca; Boggio, Elena; Dianzani, Umberto; Dianzani, Chiara | |
| Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro and in vivo studies | 2018 | Clemente, Nausicaa; Ferrara, Benedetta; Gigliotti, Casimiro Luca; Boggio, Elena; Capucchio, Maria Teresa; Biasibetti, Elena; Schiffer, Davide; Mellai, Marta; Annovazzi, Laura; Cangemi, Luigi; Muntoni, Elisabetta; Miglio, Gianluca; Dianzani, Umberto; Battaglia, Luigi*; Dianzani, Chiara | |
| The activation of glucocorticoid system that follows acute stressor exposure is blocked by alpha-MSH. | 2003 | Spaccamiglio A.; Abbadessa G; Cangemi L; Esculapio P; Portaleone P; Racca S; Di Carlo F. |